The Valley Desk

NCT02706899 · Interventional trial

Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Myelodysplastic Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov